In addition, spironolactone as mineralocorticoid receptor antagonist was shown to improve cognition in mouse models of type II diabetes80 and Alzheimer’s disease.81 The gene discussed is NR3C2; the disease is early-onset autosomal dominant Alzheimer disease.